Differential increased survival of staphylococci and limited ultrastructural changes in the core of infected fibrin clots after daptomycin administration

被引:12
作者
Michiels, MJ
Bergeron, MG
机构
[1] CHU LAVAL,CTR RECH INFECTIOL,LAB SERV INFECTIOL,QUEBEC CITY,PQ G1V 4G2,CANADA
[2] UNIV LAVAL,FAC MED,DEPT MICROBIOL,QUEBEC CITY,PQ G1V 4G2,CANADA
关键词
D O I
10.1128/AAC.40.1.203
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A possible explanation for the difficulties encountered in curing deep fibrin-embedded infections is that antibiotic diffusion inside the infected fibrin matrix is not homogeneous and is insufficient to neutralize the patho gen. To evaluate this conjecture, the differential pharmacodynamics of daptomycin in fibrin clots infected with methicillin-susceptible and -resistant Staphylococcus aureus and Staphylococcus epidermidis nas estimated. Daptomycin (20 or 50 mg/kg of body weight) was infused over 30 min. Fibrin clots and blood samples were evaluated from 0.5 to 42 h after the injections. The half-lives of daptomycin in serum and fibrin clot were close to identical after the two doses and averaged 5.4 and 22 h, respectively. The mean areas under the concentration-time curves from 0 to 42 h (AUC(0-infinity)) for daptomycin concentrations in serum and infected clots were 575 +/- 36.7 and 215 +/- 6.2 mu g/g/h after administration of 20 mg/kg and 1,089 +/- 39.9 and 326 +/- 16.8 mu g/g/h after administration of 50 mg/kg, A concentration gradient from the periphery to the core of the clots was observed in many clots up to 18 h after treatment. Mean peak concentrations in the core of the clots reached 60% of the peripheral values (P < 0.05) and were delayed for at least 3 h compared with the peripheral peak concentrations. AUC(0-42 h) of daptomycin concentration in the periphery and the core of clots were significantly different (P < 0.01). Survival of microorganisms was better in the core than in the periphery, with as much as a 3 log(10) CFU/g difference between the center and the surface of the clot. Bacterial examination by transmission electron microscopy also showed noticeable differences in ultrastructural changes between those in the periphery and those in the core of the clots. In conclusion, the pharmacokinetics of daptomycin are significantly different at the periphery and within the core of fibrin clots, which may have led to the higher bacterial survival in the core of clots. Limited diffusion of daptomycin in fibrin, an essential component of the vegetation in bacterial endocarditis, could explain at least in part some of the treatment failures.
引用
收藏
页码:203 / 211
页数:9
相关论文
共 30 条
[1]   DAPTOMYCIN DISRUPTS MEMBRANE-POTENTIAL IN GROWING STAPHYLOCOCCUS-AUREUS [J].
ALBORN, WE ;
ALLEN, NE ;
PRESTON, DA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (11) :2282-2287
[2]  
ALLEN NE, 1991, ANTIMICROB AGENTS CH, V5, P2639
[3]   INTRAVEGETATION ANTIMICROBIAL DISTRIBUTION IN AORTIC ENDOCARDITIS ANALYZED BY COMPUTER-GENERATED MODEL - IMPLICATIONS FOR TREATMENT [J].
BAYER, AS ;
CROWELL, D ;
NAST, CC ;
NORMAN, DC ;
BORRELLI, RL .
CHEST, 1990, 97 (03) :611-617
[4]   PHARMACODYNAMICS OF ANTIBIOTICS IN FIBRIN CLOTS [J].
BERGERON, MG ;
ROBERT, J ;
BEAUCHAMP, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 :113-136
[5]  
BERGERON MG, 1986, EXPT MODELS ANTIMICR, V1, P71
[6]   SPECIFIC BINDING OF THE HUMAN S-PROTEIN (VITRONECTIN) TO STREPTOCOCCI, STAPHYLOCOCCUS-AUREUS, AND ESCHERICHIA-COLI [J].
CHHATWAL, GS ;
PREISSNER, KT ;
MULLERBERGHAUS, G ;
BLOBEL, H .
INFECTION AND IMMUNITY, 1987, 55 (08) :1878-1883
[7]   EVALUATION OF ANTIBIOTIC DIFFUSION INTO CARDIAC VEGETATIONS BY QUANTITATIVE AUTORADIOGRAPHY [J].
CREMIEUX, AC ;
MAZIERE, B ;
VALLOIS, JM ;
OTTAVIANI, M ;
AZANCOT, A ;
RAFFOUL, H ;
BOUVET, A ;
POCIDALO, JJ ;
CARBON, C .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (05) :938-944
[8]   INVITRO ACTIVITIES OF DAPTOMYCIN AND OTHER ANTIMICROBIAL AGENTS AGAINST VANCOMYCIN-RESISTANT GRAM-POSITIVE BACTERIA [J].
DELAMAZA, L ;
RUOFF, KL ;
FERRARO, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) :1383-1384
[9]   INVITRO AND INVIVO ACTIVITY OF LY 146032, A NEW CYCLIC LIPOPEPTIDE ANTIBIOTIC [J].
ELIOPOULOS, GM ;
WILLEY, S ;
REISZNER, E ;
SPITZER, PG ;
CAPUTO, G ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (04) :532-535
[10]  
Friedman M, 1938, J PHARMACOL EXP THER, V63, P173